---
figid: PMC7563273__jcm-09-02934-g003
figlink: pmc/articles/PMC7563273/figure/jcm-09-02934-f003/
number: F3
caption: Targeting the PI3K/Akt/mTOR pathway in AML. The PI3K/Akt/mTOR pathway is
  commonly dysregulated in AML caused by mutations in membrane-bound proteins such
  as receptor tyrosine kinases (RTKs) and small GTPase Ras. Activating mutations in
  fms-like tyrosine kinase 3 (FLT3), such as the FLT3-internal tandem duplication
  (FLT3-ITD), are an important mechanism leading to dysregulation of PI3K/Akt/mTOR
  signaling. The ITD mutation causes ligand-independent activation of the FLT3 receptor,
  leading to constitutive activation of the PI3K/Akt/mTOR pathway. Numerous small-molecule
  inhibitors of this pathway include FLT3 inhibitors (FLT3i), dual PI3K/mTORi, allosteric
  mTORi, pan-class I and isoform-specific PI3Ki, ATP-competitive and allosteric Akti,
  and ATP-competitive mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2) inhibitors
  (mTORC1i and mTORC2i). The red arrow indicates elevated Akt phosphorylation, whereas
  the red blunt-ended lines represent negative regulation (inhibition). IRS-1 = insulin
  receptor substrate 1, PIP2 = phosphatidylinositol-4,5-phosphate, PIP3 = phosphatidylinositol-3,4,5-phosphate,
  PTEN = phosphatase and tensin homolog, PDK1 = phosphoinositide-dependent kinase-1,
  TSC 1/2 = tuberous sclerosis complex 1/2, ATP = adenosine triphosphate, GDP = guanosine
  diphosphate, GTP = guanosine triphosphate, Rheb = Ras homolog enriched in brain,
  4E-BP1 = eukaryotic translation initiation factor 4E (eIF4E)-binding protein 1,
  S6K1 = ribosomal protein S6 kinase beta-1, rpS6 = ribosomal protein S6. The black
  blunt-ended lines indicate the main targets for therapeutic intervention. Created
  with BioRender.com.
pmcid: PMC7563273
papertitle: 'Targeting PI3K/Akt/mTOR in AML: Rationale and Clinical Evidence.'
reftext: Salihanur Darici, et al. J Clin Med. 2020 Sep;9(9):2934.
pmc_ranked_result_index: '82242'
pathway_score: 0.9233638
filename: jcm-09-02934-g003.jpg
figtitle: Targeting the PI3K/Akt/mTOR pathway in AML
year: '2020'
organisms:
- Mus musculus
- Rattus norvegicus
- Streptomyces hygroscopicus
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7563273__jcm-09-02934-g003.html
  '@type': Dataset
  description: Targeting the PI3K/Akt/mTOR pathway in AML. The PI3K/Akt/mTOR pathway
    is commonly dysregulated in AML caused by mutations in membrane-bound proteins
    such as receptor tyrosine kinases (RTKs) and small GTPase Ras. Activating mutations
    in fms-like tyrosine kinase 3 (FLT3), such as the FLT3-internal tandem duplication
    (FLT3-ITD), are an important mechanism leading to dysregulation of PI3K/Akt/mTOR
    signaling. The ITD mutation causes ligand-independent activation of the FLT3 receptor,
    leading to constitutive activation of the PI3K/Akt/mTOR pathway. Numerous small-molecule
    inhibitors of this pathway include FLT3 inhibitors (FLT3i), dual PI3K/mTORi, allosteric
    mTORi, pan-class I and isoform-specific PI3Ki, ATP-competitive and allosteric
    Akti, and ATP-competitive mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2)
    inhibitors (mTORC1i and mTORC2i). The red arrow indicates elevated Akt phosphorylation,
    whereas the red blunt-ended lines represent negative regulation (inhibition).
    IRS-1 = insulin receptor substrate 1, PIP2 = phosphatidylinositol-4,5-phosphate,
    PIP3 = phosphatidylinositol-3,4,5-phosphate, PTEN = phosphatase and tensin homolog,
    PDK1 = phosphoinositide-dependent kinase-1, TSC 1/2 = tuberous sclerosis complex
    1/2, ATP = adenosine triphosphate, GDP = guanosine diphosphate, GTP = guanosine
    triphosphate, Rheb = Ras homolog enriched in brain, 4E-BP1 = eukaryotic translation
    initiation factor 4E (eIF4E)-binding protein 1, S6K1 = ribosomal protein S6 kinase
    beta-1, rpS6 = ribosomal protein S6. The black blunt-ended lines indicate the
    main targets for therapeutic intervention. Created with BioRender.com.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - PTEN
  - IRS1
  - PDK1
  - SART3
  - PIK3CA
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3CB
  - PIK3CD
  - PIK3R5
  - PIK3R6
  - AKT2
  - AKT3
  - AKT1
  - TSC1
  - TSC2
  - RHEB
  - EIF4EBP1
  - STK25
  - RPS6KB1
  - EIF4E
  - RPS6
  - ATP
  - GDP
  - hematopoiesis
  - myeloid leukemia
genes:
- word: PTEN
  symbol: PTEN
  source: hgnc_symbol
  hgnc_symbol: PTEN
  entrez: '5728'
- word: PTEN
  symbol: PTEN
  source: hgnc_symbol
  hgnc_symbol: PTEN
  entrez: '5728'
- word: IRS-1
  symbol: IRS1
  source: hgnc_symbol
  hgnc_symbol: IRS1
  entrez: '3667'
- word: IRS-1
  symbol: IRS1
  source: hgnc_symbol
  hgnc_symbol: IRS1
  entrez: '3667'
- word: PDK1
  symbol: PDK1
  source: hgnc_symbol
  hgnc_symbol: PDK1
  entrez: '5163'
- word: p110
  symbol: p110
  source: hgnc_alias_symbol
  hgnc_symbol: SART3
  entrez: '9733'
- word: PDK1
  symbol: PDK1
  source: hgnc_symbol
  hgnc_symbol: PDK1
  entrez: '5163'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: PI3K/
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: PI3K/
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: PI3K/
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: PI3K/
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: PI3K/
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: PI3K/
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: PI3K/
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: PI3K/
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: TSC1/2
  symbol: TSC1
  source: hgnc_symbol
  hgnc_symbol: TSC1
  entrez: '7248'
- word: TSC1/2
  symbol: TSC2
  source: hgnc_symbol
  hgnc_symbol: TSC2
  entrez: '7249'
- word: TSC1/2
  symbol: TSC1
  source: hgnc_symbol
  hgnc_symbol: TSC1
  entrez: '7248'
- word: TSC1/2
  symbol: TSC2
  source: hgnc_symbol
  hgnc_symbol: TSC2
  entrez: '7249'
- word: Rheb
  symbol: RHEB
  source: hgnc_symbol
  hgnc_symbol: RHEB
  entrez: '6009'
- word: Rheb
  symbol: RHEB
  source: hgnc_symbol
  hgnc_symbol: RHEB
  entrez: '6009'
- word: Rheb
  symbol: RHEB
  source: hgnc_symbol
  hgnc_symbol: RHEB
  entrez: '6009'
- word: Rheb
  symbol: RHEB
  source: hgnc_symbol
  hgnc_symbol: RHEB
  entrez: '6009'
- word: 4E-BP1
  symbol: 4E-BP1
  source: hgnc_alias_symbol
  hgnc_symbol: EIF4EBP1
  entrez: '1978'
- word: SOK1
  symbol: SOK1
  source: hgnc_alias_symbol
  hgnc_symbol: STK25
  entrez: '10494'
- word: 4E-BP1
  symbol: 4E-BP1
  source: hgnc_alias_symbol
  hgnc_symbol: EIF4EBP1
  entrez: '1978'
- word: S6K1
  symbol: S6K1
  source: hgnc_alias_symbol
  hgnc_symbol: RPS6KB1
  entrez: '6198'
- word: elF4E
  symbol: EIF4E
  source: hgnc_symbol
  hgnc_symbol: EIF4E
  entrez: '1977'
- word: rps6
  symbol: RPS6
  source: hgnc_symbol
  hgnc_symbol: RPS6
  entrez: '6194'
- word: elF4E
  symbol: EIF4E
  source: hgnc_symbol
  hgnc_symbol: EIF4E
  entrez: '1977'
- word: rps6
  symbol: RPS6
  source: hgnc_symbol
  hgnc_symbol: RPS6
  entrez: '6194'
chemicals:
- word: ATP
  source: MESH
  identifier: D000255
- word: GDP
  source: MESH
  identifier: D006153
diseases:
- word: hematopoiesis
  source: MESH
  identifier: C536227
- word: myeloid leukemia
  source: MESH
  identifier: D007951
figid_alias: PMC7563273__F3
redirect_from: /figures/PMC7563273__F3
figtype: Figure
---
